We Probably have the Answer: Now What is the Question?
Activities in the Field of Lung Cancer Coordinated by the Section of Applied Radiation Biology and Radiotherapy of the International Atomic Energy Agency
Acetylcholine Receptor Pathway and Lung Cancer
Efficacy of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Hilar Lymph Nodes for Diagnosing and Staging Cancer
Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node Metastasis
Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival
Results of Surgical Treatment for Patients with Small Cell Lung Cancer
Phase II Trial of Neoadjuvant Therapy with Carboplatin, Gemcitabine plus Thalidomide for Stages IIB and III Non-small Cell Lung Cancer
A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer
Impact of the ASCO 2007 Presentation of HOG Lun 01-24/USO-023 on the Prescribing Plans of American Medical Oncologists for Patients with Stage IIIB Non-small Cell Lung Cancer
Gefitinib in Combination with Gemcitabine and Carboplatin in Never Smokers with Non-small Cell Lung Carcinoma
Response Rate Is Associated with Prolonged Survival in Patients with Advanced Non-small Cell Lung Cancer Treated with Gefitinib or Erlotinib
A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer
Outcome for Patients with Malignant Pleural Mesothelioma Referred for Trimodality Therapy in Western Australia
Second-Line Combination Chemotherapy with Docetaxel and Nedaplatin for Cisplatin-Pretreated Refractory Metastatic/Recurrent Esophageal Squamous Cell Carcinoma
Resection of Thyroid Cancer Metastases to the Sternum
Pulmonary Metastasis of Basal Cell Carcinoma
MicroRNAs in the Pathogenesis of Lung Cancer
Chest Wall Pain and Rib Fracture after Stereotactic Radiotherapy for Peripheral Non-small Cell Lung Cancer
Localized Malignant Pleural Mesothelioma
Letters to the Editor
In Response:
ERCC1 and RRM1 Expression in Nonsmall Cell Lung Cancer—The Good, the Bad and the Unknown
Wood-Smoke Exposure as a Response and Survival Predictor in Erlotinib-Treated Nonsmall Cell Lung Cancer Patients
Esophageal Ultrasound-Controlled Fine Needle Aspiration for Staging of Mediastinal Lymph Nodes in Patients with Resectable Lung Cancer: Do We Always See the Reality?